
Metcamp XL 23.75mg Tablet
Marketer
Lakarez Pharmaceuticals Private Limited
Salt Composition
Metoprolol Succinate (23.75mg)
Overview Metcamp XL 23.75mg Tablet
Extended-release Metoprolol Succinate 23.75mg tablets are classified as beta-adrenergic blocking agents. This medication treats hypertension, angina pectoris, and cardiac arrhythmias. It also aids in migraine prevention and reducing the risk of recurrent myocardial infarction and stroke. Dosage and administration frequency vary depending on the indication and condition severity; it may be used alone or in combination with other therapies. Administer consistently at the same time each day, with or without food, for optimal efficacy. Full therapeutic benefit may take several weeks, and continuous use might be necessary. Discontinuation may exacerbate the underlying condition. Common, generally mild and transient, adverse effects include fatigue, cephalgia, depressive symptoms, diarrhea, skin rashes, bradycardia, dizziness, and nausea. Less frequently, dyspnea or hypotension can occur. Gradual dose escalation minimizes adverse reactions. Report persistent or bothersome side effects to your physician. Prior to initiating therapy, disclose any hepatic impairment. This medication is contraindicated in patients with bradycardia, severe peripheral vascular disease, decompensated heart failure, or hypotension. Pregnant or lactating individuals require medical consultation. Appropriate use should be determined by your doctor through regular blood pressure monitoring. Alcohol consumption should be limited due to potential exacerbation of side effects.
Uses of Metcamp XL 23.75mg Tablet
Managing angina pectoris (chest pain from heart disease) | Addressing cardiac arrhythmias | Reducing the risk of myocardial infarction | Hypertension (high blood pressure) management | Migraine prophylaxis
Major Benefits of Metcamp XL 23.75mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Metcamp XL 23.75mg Tablets can be taken with or without food, though consistent timing is recommended. Minimize consumption of Metcamp XL 23.75mg Tablets alongside meals rich in fat, including those containing olive oil, nuts (especially Brazil nuts), dark chocolate, butter, and red meat.
Common Side effects of Metcamp XL 23.75mg Tablet:
- Tiredness
- Dizziness
- Depression
- Breathlessness
- Headache
- Slow heart rate
- Nausea
- Rash
- Diarrhea
- Hypotension (low blood pressure)
How to use Metcamp XL 23.75mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Metcamp XL 23.75mg Tablets can be consumed with or without food, although consistent timing is recommended. To optimize absorption, it's advisable to avoid taking Metcamp XL 23.75mg Tablets with meals high in fat, including those containing olive oil, nuts (like Brazil nuts), dark chocolate, butter, and red meat.
How Metcamp XL 23.75mg Tablet works:
Extended-release metoprolol succinate 23.75 mg tablets are a cardioselective beta-adrenergic blocking agent. Their mechanism involves reducing heart rate and enhancing the heart's pumping efficiency, improving circulatory function.
SAFETY ADVICE
AlcoholUNSAFE
Combining Metcamp XL 23.75mg tablets with alcohol is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Metcamp XL 23.75mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release metcamp 23.75mg tablets are likely safe for use while breastfeeding. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Taking a Metcamp XL 23.75mg tablet can lead to drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these side effects.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely take Metcamp XL 23.75mg tablets without requiring any dosage modification.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Metcamp XL 23.75mg tablets. Dosage modification of Metcamp XL 23.75mg tablets may be necessary. Physician consultation is advised.
What if you forget to take Metcamp XL 23.75mg Tablet :
Should you forget a Metcamp XL 23.75mg Tablet, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual regimen. Avoid taking a double dose.
Facts to Know About Metcamp XL 23.75mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Alcohols and Phenols |
| Developing Habits | No. |
| Treatment Category | Heart |
